Trial · NCT00646399
Adverse events34
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 34
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Pagibaximab | 479 | 784 | 646 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo | 487 | 778 | 665 |
| other | Hypothyroidism | Endocrine disorders | Pagibaximab | 9 | 784 | 9 |
| other | Hypothyroidism | Endocrine disorders | Placebo | 17 | 778 | 17 |
| other | Gastrooesophageal Reflux Disease | Gastrointestinal disorders | Pagibaximab | 85 | 784 | 85 |
| other | Gastrooesophageal Reflux Disease | Gastrointestinal disorders | Placebo | 79 | 778 | 79 |
| other | Feeding Disorder Neonatal | Metabolism and nutrition disorders | Pagibaximab | 204 | 784 | 221 |
| other | Feeding Disorder Neonatal | Metabolism and nutrition disorders | Placebo | 194 | 778 | 209 |
| other | Ophthalmia Neonatorum | Infections and infestations | Pagibaximab | 56 | 784 | 58 |
| other | Ophthalmia Neonatorum | Infections and infestations | Placebo | 41 | 778 | 48 |
| other | Cardiac Murmur | Investigations | Pagibaximab | 48 | 784 | 50 |
| other | Cardiac Murmur | Investigations | Placebo | 45 | 778 | 49 |
| other | Hyperbilirubinaemia | Hepatobiliary disorders | Pagibaximab | 128 | 784 | 137 |
| other | Hyperbilirubinaemia | Hepatobiliary disorders | Placebo | 112 | 778 | 113 |
| serious | Necrotizing Colitis | Gastrointestinal disorders | Pagibaximab | 52 | 784 | 52 |
| serious | Necrotizing Colitis | Gastrointestinal disorders | Placebo | 42 | 778 | 42 |
| serious | Intraventricular Haemorrhage | Nervous system disorders | Pagibaximab | 55 | 784 | 56 |
| serious | Intraventricular Haemorrhage | Nervous system disorders | Placebo | 57 | 778 | 58 |
| serious | Patent Ductus Arteriosus | Congenital, familial and genetic disorders | Pagibaximab | 104 | 784 | 104 |
| serious | Patent Ductus Arteriosus | Congenital, familial and genetic disorders | Placebo | 110 | 778 | 110 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00646399/events